Radiotherapy in age related macular degeneration: a therapeutic update

Article Sidebar

Published: Jan 31, 1999
DOI: https://doi.org/10.21315/

Main Article Content

B.M. Biswal
Department of Nuclear Medicine, Radiotherapy and Oncology, Department of Opthalmology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan
S.C. Reddy
Department of Nuclear Medicine, Radiotherapy and Oncology, Department of Opthalmology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan

Abstract

Age related macular degeneration (ARMD) leads to progressive deterioration of vision among elderly peoples over sixth decade of life. The only established treatment with laser is suitable for very small group of patient and remaining patients are allowed to follow its natural course. Currently there is overwhelming interest in the use of radiotherapy in proliferative ARMD with demonstrable decrease in the neovascular membrane, improvement or stabilization of the visual acuity and control of macular exudation. A precise radiation dose of 12-20 Gy in 5-10 fractions to the posterior segment of the eye seems optimum with least possible radiation complications. Here we review the existing literature on the usefulness of radiotherapy in ARMD.

Article Details

How to Cite
1.
B.M. Biswal, S.C. Reddy. Radiotherapy in age related macular degeneration: a therapeutic update. Malays J Med Sci [Internet]. 1999 Jan. 31 [cited 2026 Oct. 18];6(1):6-11. Available from: https://ejournal.usm.my/mjms/article/view/mjms_vol6-no-1-1999_2
Issue
Vol. 6 No. 1 (1999): Abstracts
Section
Abstract
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.